{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:10:28Z","timestamp":1760145028623,"version":"build-2065373602"},"reference-count":49,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: This study demonstrates the factor structure and reliability of the Croatian version of the TOPICOP (Topical Corticosteroid Phobia) questionnaire, thereby contributing to further validation and standardization of the measurement of topical corticophobia with dermatological patients or their parents, which directly affects patient or parent compliance, as well as the final therapeutic effect. Materials and Methods: The cross-sectional, observational study was conducted at the University Hospital Centre Split, Department of Dermatovenerology. The research involved inviting 120 participants (age 12\u201368) who attended the University Hospital Centre Split\u2019s Atopy School, patients examined in the Dermatology Outpatient Clinic of the University Hospital Centre Split and diagnosed with atopic dermatitis (AD) or allergic contact dermatitis (ACD), and parents or legal representatives of patients younger than 12 years old. The TOPICOP questionnaire consists of 12 items assessing the three different components of topical corticophobia (worries, beliefs, and behaviour). Respondents evaluated their perception of the correctness of each statement within 10 min of filling out the questionnaire on a four-point Likert scale. Results: The response rate was 94%, resulting in a sample of 113 respondents (109 adults and 4 children). Factor analysis yielded one common factor of relatively high reliability (Cronbach \u03b1 = 0.85, 95% CI 0.81 to 0.89). No differences were found in questionnaire scores between male and female participants, nor between the parents\/legal representatives of dermatological patients and other patients. Conclusions: This research contributes to further development of the appropriate measuring instrument, its practical application, and thus, the better recognition, resolution, and prevention of topical corticophobia as part of the better overall healthcare and treatment of chronic dermatological patients.<\/jats:p>","DOI":"10.3390\/medicina60060968","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T06:47:30Z","timestamp":1718174850000},"page":"968","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Linguistic Validation and Reliability of the Croatian Version of the TOPICOP Questionnaire"],"prefix":"10.3390","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5964-8982","authenticated-orcid":false,"given":"Adela","family":"Markota \u010cagalj","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology, University Hospital of Split, Spin\u010di\u0107eva 1, 21000 Split, Croatia"},{"name":"School of Medicine, University of Split, \u0160oltanska 2, 21000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9469-9278","authenticated-orcid":false,"given":"Josko","family":"Markic","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Split, \u0160oltanska 2, 21000 Split, Croatia"},{"name":"Department of Pediatrics, University Hospital of Split, Spin\u010di\u0107eva 1, 21000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dubravka","family":"Vukovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, University Hospital of Split, Spin\u010di\u0107eva 1, 21000 Split, Croatia"},{"name":"School of Medicine, University of Split, \u0160oltanska 2, 21000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3009-9566","authenticated-orcid":false,"given":"Zdenka","family":"\u0160itum \u010ceprnja","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, University Hospital of Split, Spin\u010di\u0107eva 1, 21000 Split, Croatia"},{"name":"School of Medicine, University of Split, \u0160oltanska 2, 21000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Gogi\u0107 Salapi\u0107","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, University Hospital of Split, Spin\u010di\u0107eva 1, 21000 Split, Croatia"},{"name":"School of Medicine, University of Split, \u0160oltanska 2, 21000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Buljan","sequence":"additional","affiliation":[{"name":"Department of Psychology, Faculty of Humanities and Social Sciences in Split, University of Split, Polji\u010dka cesta 35, 21000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5524-1723","authenticated-orcid":false,"given":"Shelly Melissa","family":"Prani\u0107","sequence":"additional","affiliation":[{"name":"Department of Public Health, School of Medicine, University of Split, Cohrane Croatia, \u0160oltanska 2, 21000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"doi-asserted-by":"crossref","unstructured":"Sroka-Tomaszewska, J., and Trzeciak, M. (2021). Molecular Mechanisms of Atopic Dermatitis Pathogenesis. Int. J. Mol. Sci., 22.","key":"ref_1","DOI":"10.3390\/ijms22084130"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/bjd\/ljad339","article-title":"Global Epidemiology of Atopic Dermatitis: A Comprehensive Systematic Analysis and Modelling Study","volume":"190","author":"Tian","year":"2023","journal-title":"Br. J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/pde.13698","article-title":"Corticosteroid Phobia (Corticophobia) in Parents of Young Children with Atopic Dermatitis and Their Health Care Providers","volume":"36","author":"Bos","year":"2019","journal-title":"Pediatr. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/all.12270","article-title":"New Insights into the Epidemiology of Childhood Atopic Dermatitis","volume":"69","author":"Flohr","year":"2014","journal-title":"Allergy"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaip.2019.06.044","article-title":"Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection","volume":"8","author":"Fishbein","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mcna.2019.08.012","article-title":"Allergic Contact Dermatitis","volume":"104","author":"Nassau","year":"2020","journal-title":"Med. Clin. N. Am."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-021-00271-4","article-title":"Contact Dermatitis","volume":"7","author":"Scheinman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1184289","DOI":"10.3389\/fmed.2023.1184289","article-title":"Advancing the Understanding of Allergic Contact Dermatitis: From Pathophysiology to Novel Therapeutic Approaches","volume":"10","author":"Tramontana","year":"2023","journal-title":"Front. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.clindermatol.2013.05.033","article-title":"Contact Dermatitis: Allergic and Irritant","volume":"32","author":"Tan","year":"2014","journal-title":"Clin. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.anai.2020.10.003","article-title":"A Review of Contact Dermatitis","volume":"126","author":"Brar","year":"2021","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40257-017-0340-7","article-title":"The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis","volume":"19","author":"Owen","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s40257-021-00629-0","article-title":"Appraisal of Proactive Topical Therapy in Atopic Dermatitis: Pros and Cons","volume":"22","author":"Thyssen","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_13","first-page":"337","article-title":"Topical Corticosteroids: Choice and Application","volume":"103","author":"Stacey","year":"2021","journal-title":"Am. Fam. Physician"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","article-title":"Adverse Effects of Topical Glucocorticosteroids","volume":"54","author":"Hengge","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/09546630701441723","article-title":"The Fingertip Unit: A Practical Guide to Topical Therapy in Children","volume":"18","author":"Kalavala","year":"2007","journal-title":"J. Dermatolog. Treat."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s11096-021-01241-2","article-title":"Reducing Corticosteroid Phobia in Pharmacy Staff and Parents of Children with Atopic Dermatitis","volume":"43","author":"Koster","year":"2021","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamadermatol.2017.2437","article-title":"Topical Corticosteroid Phobia in Atopic Dermatitis: A Systematic Review","volume":"153","author":"Li","year":"2017","journal-title":"JAMA Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1525-1470.2012.01808.x","article-title":"Factors Associated with Steroid Phobia in Caregivers of Children with Atopic Dermatitis","volume":"30","author":"Kojima","year":"2013","journal-title":"Pediatr. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.5021\/ad.2015.27.5.499","article-title":"Topical Corticosteroid Phobia among Parents of Children with Atopic Eczema in Korea","volume":"27","author":"Lee","year":"2015","journal-title":"Ann. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/ced\/llac019","article-title":"#corticophobia: A Review on Online Misinformation Related to Topical Steroids","volume":"48","author":"Finnegan","year":"2023","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s40257-021-00623-6","article-title":"Steroid Phobia: A Review of Prevalence, Risk Factors, and Interventions","volume":"22","author":"Contento","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15586\/aei.v49i2.47","article-title":"Evaluation of Atopy Schools for Parents","volume":"49","author":"Burgos","year":"2021","journal-title":"Allergol. Immunopathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.11622\/smedj.2019110","article-title":"Corticosteroid Phobia: A Questionnaire Study Using TOPICOP Score","volume":"61","author":"Choi","year":"2020","journal-title":"Singap. Med. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/all.13189","article-title":"Topical Corticosteroid Phobia in Atopic Dermatitis: International Feasibility Study of the TOPICOP Score","volume":"72","author":"Stalder","year":"2017","journal-title":"Allergy"},{"doi-asserted-by":"crossref","unstructured":"Moret, L., Anthoine, E., Aubert-Wastiaux, H., Le Rhun, A., Leux, C., Mazereeuw-Hautier, J., Stalder, J.-F., and Barbarot, S. (2013). TOPICOP\u00a9: A New Scale Evaluating Topical Corticosteroid Phobia among Atopic Dermatitis Outpatients and Their Parents. PLoS ONE, 8.","key":"ref_25","DOI":"10.1371\/journal.pone.0076493"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jaad.2013.10.010","article-title":"Guidelines of Care for the Management of Atopic Dermatitis: Section 1. Diagnosis and Assessment of Atopic Dermatitis","volume":"70","author":"Eichenfield","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"adv00161","DOI":"10.2340\/00015555-3511","article-title":"Counting the Burden: Atopic Dermatitis and Health-Related Quality of Life","volume":"100","author":"Ali","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0895-4356(96)00363-0","article-title":"Methodological Approaches to Shortening Composite Measurement Scales","volume":"50","author":"Coste","year":"1997","journal-title":"J. Clin. Epidemiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02310555","article-title":"Coefficient Alpha and the Internal Structure of Tests","volume":"16","author":"Cronbach","year":"1951","journal-title":"Psychometrika"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1007\/BF00638237","article-title":"Therapy with Topical Corticosteroids","volume":"284","author":"Sterry","year":"1992","journal-title":"Arch. Dermatol. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.chc.2005.05.004","article-title":"Specific Phobia","volume":"14","author":"Silverman","year":"2005","journal-title":"Child. Adolesc. Psychiatr. Clin. N. Am."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1365-2133.2000.03473.x","article-title":"Topical Corticosteroid Phobia in Patients with Atopic Eczema","volume":"142","author":"Charman","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1440-0960.1996.tb01070.x","article-title":"Compliance Problems in Paediatric Atopic Eczema","volume":"37","author":"Fischer","year":"1996","journal-title":"Australas. J. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1080\/08035250600612298","article-title":"Steroid Fears in Children with Eczema","volume":"95","author":"Hon","year":"2006","journal-title":"Acta Paediatr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1365-2133.2011.10449.x","article-title":"Topical Corticosteroid Phobia in Atopic Dermatitis: A Study of Its Nature, Origins and Frequency","volume":"165","author":"Moret","year":"2011","journal-title":"Br. J. Dermatol."},{"doi-asserted-by":"crossref","unstructured":"Herzum, A., Occella, C., Gariazzo, L., Pastorino, C., and Viglizzo, G. (2023). Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores. J. Clin. Med., 12.","key":"ref_36","DOI":"10.3390\/jcm12216813"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/pai.13394","article-title":"Healthcare Utilization in Danish Children with Atopic Dermatitis and Parental Topical Corticosteroid Phobia","volume":"32","author":"Gerner","year":"2021","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2340\/00015555-3220","article-title":"Topical Corticosteroid Phobia Among Healthcare Professionals Using the TOPICOP Score","volume":"99","author":"Lambrechts","year":"2019","journal-title":"Acta Derm. Venereol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1002\/ski2.143","article-title":"Long Term Effects of Digital Education among Healthcare Professionals in Paediatric Dermatology: Opportunities for Improving Care","volume":"2","author":"Ragamin","year":"2022","journal-title":"Skin Health Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.2196\/jmir.3.2.e15","article-title":"The Patient Physician Relationship in the Internet Age: Future Prospects and the Research Agenda","volume":"3","author":"Gerber","year":"2001","journal-title":"J. Med. Internet Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/bmj.325.7366.697","article-title":"Key Communication Skills and How to Acquire Them","volume":"325","author":"Maguire","year":"2002","journal-title":"BMJ"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0009922807305650","article-title":"The Clinician-Patient Partnership Paradigm: Outcomes Associated with Physician Communication Behavior","volume":"47","author":"Clark","year":"2008","journal-title":"Clin. Pediatr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/09546634.2019.1657221","article-title":"TOPICOP\u00a9 Scale for Steroid Phobia\u2014Difficulties and Suggestions for Application in Clinical Research","volume":"31","author":"Yin","year":"2020","journal-title":"J. Dermatolog. Treat."},{"key":"ref_44","first-page":"135","article-title":"Evaluation of Corticophobia in Patients with Atopic Dermatitis and Psoriasis Using the TOPICOP\u00a9 Score","volume":"32","author":"Benko","year":"2023","journal-title":"Acta Dermatovenerol. Alpina Pannonica Adriat."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.abd.2021.11.007","article-title":"A Low Level of Health Literacy Is a Predictor of Corticophobia in Atopic Dermatitis","volume":"97","author":"Gomes","year":"2022","journal-title":"An. Bras. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1080\/09546634.2021.1959505","article-title":"Assessment of Topical Steroid Phobia in Dermatology Patients, a Cross-Sectional Study from an Urban Area of Pakistan","volume":"33","author":"Masood","year":"2022","journal-title":"J. Dermatolog. Treat."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.2147\/PPA.S431719","article-title":"Topical Corticosteroid Phobia Among Parents of Children with Atopic Dermatitis (Eczema)- A Cross-Sectional Study","volume":"17","author":"Albogami","year":"2023","journal-title":"Patient Prefer. Adherence"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/pde.15183","article-title":"Topical Corticosteroid Phobia in Adolescents with Eczema and Caregivers of Children and Adolescents with Eczema: A Cross-Sectional Survey","volume":"40","author":"Tangthanapalakul","year":"2023","journal-title":"Pediatr. Dermatol."},{"key":"ref_49","first-page":"66","article-title":"The Japanese Version Of Topicop Scale Among Patients With Atopic Dermatitis: A Translation And Feasibility Study","volume":"65","author":"Futamura","year":"2016","journal-title":"Arerugi"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/6\/968\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:57:07Z","timestamp":1760108227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/6\/968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["medicina60060968"],"URL":"https:\/\/doi.org\/10.3390\/medicina60060968","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2024,6,12]]}}}